埃博拉病毒糖蛋白的内体蛋白解对于感染是必要的
Kartik Chandran1, Nancy J Sullivan, Ute Felbor
1Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
概括
埃博拉病毒进入细胞取决于内体细胞内蛋白酶,特别是甲素B (CatB). 抑制CatB和CatL显示出开发新的抗埃博拉病毒药物的潜力.
科学领域:
- 病毒学 病毒学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 埃博拉病毒 (EboV) 导致严重的出血热,目前没有治疗方法.
- 病毒进入机制对于理解和对抗感染至关重要.
研究的目的:
- 为了研究内体蛋白酶在EboV糖蛋白 (GP) 介导的细胞进入中的作用.
- 为了确定EboV感染所必需的特定蛋白酶.
主要方法:
- 使用了带状口炎病毒,其伪型为EboV GP.
- 采用选择性蛋白酶抑制剂和蛋白酶缺乏细胞系.
- 对EboV GP处理进行了生化研究.
主要成果:
- 内体囊蛋白酶对于EboV GP-依赖的病毒进入至关重要.
- 甲素B (CatB) 起到重要作用,而甲素L (CatL) 起到辅助作用.
- CatB和CatL通过蛋白质分解处理EboV GP子单元GP1,促进病毒的进入.
- CatB和CatL的抑制剂减少了细胞培养中的感染性EboV-Zaire复制.
结论:
- 甲素B和L是EboV进入的关键宿主因素.
- 准这些蛋白酶代表了对抗EboV感染的有希望的治疗策略.
- 需要对CatB和CatL抑制剂作为抗埃博拉药物的进一步研究.
相关概念视频
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...


